KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Merck (MRK) Free Cash Flow (2016 - 2025)

Historic Free Cash Flow for Merck (MRK) over the last 17 years, with Q3 2025 value amounting to $6.8 billion.

  • Merck's Free Cash Flow fell 1966.38% to $6.8 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $13.0 billion, marking a year-over-year decrease of 1206.87%. This contributed to the annual value of $18.1 billion for FY2024, which is 9792.19% up from last year.
  • As of Q3 2025, Merck's Free Cash Flow stood at $6.8 billion, which was down 1966.38% from $2.5 billion recorded in Q2 2025.
  • Over the past 5 years, Merck's Free Cash Flow peaked at $8.5 billion during Q3 2024, and registered a low of -$743.0 million during Q4 2023.
  • For the 5-year period, Merck's Free Cash Flow averaged around $3.2 billion, with its median value being $3.2 billion (2022).
  • In the last 5 years, Merck's Free Cash Flow surged by 254598.54% in 2021 and then plummeted by 12264.55% in 2023.
  • Quarter analysis of 5 years shows Merck's Free Cash Flow stood at $3.9 billion in 2021, then dropped by 15.59% to $3.3 billion in 2022, then plummeted by 122.65% to -$743.0 million in 2023, then soared by 438.22% to $2.5 billion in 2024, then surged by 171.99% to $6.8 billion in 2025.
  • Its Free Cash Flow was $6.8 billion in Q3 2025, compared to $2.5 billion in Q2 2025 and $1.2 billion in Q1 2025.